Company News & press Releases
COVID-19 Initiative
important milestones
PR: Vagus Nerve Stimulation Associated with Fewer Deaths in Hospitalized COVID-19 Patients, Dec 2, 2020
OVERLAND PARK, KANSAS, UNITED STATES, December 2, 2020 /EINPresswire.com/ — Nemechek Technologies is proud to announce publication of a peer-reviewed research article by its CEO, Patrick Nemechek
PR: Bioelectric Medicine and Coronavirus? ,June 29, 2020
Is Bio-Electric Medicine the Next Frontier of Therapy for Coronavirus Victims? Just Published – Dr. Patrick Nemechek proposes new technology to suppress COVID-19 cytokine storm.
PR: VNS for COVID-19?, June 22, 2020
‘Vagus Nerve Stimulation is an Ideal Therapeutic Candidate for COVID-19 Infection’ Patrick Nemechek, D.O. – Published in The Journal of Emerging Diseases and Virology OVERLAND
PR: NemeTech Enters Collaborative Agreement, June 2, 2020
Proposed South African Study Targets COVID-19 with Bio-Electric Therapy Vagus Nerve Stimulation (VNS) trial seeks to mitigate the deadly Cytokine Storm. Overland Park, Kansas, June
PR: Planning Clinical Trial of VNS vs. COVID-19, May 20, 2020
Bio-Electric Therapy Targets Deadly COVID-19 Cytokine Storm Vagus Nerve Stimulation (VNS) Trial Seeks to Mitigate Dangerous Immune Response. Overland Park, Kansas, May 20, 2020 –
PR: – May 4, 2020
Bio-Electric Therapy Targets Deadly COVID-19 Cytokine Storm Vagus Nerve Stimulation (VNS) Trial Seeks to Mitigate Dangerous Immune Response. Overland Park, Kansas, May 20, 2020 –